Shire says gets U.S. approval signal on ADHD drug

(Reuters) - "The information requested by the FDA was not unexpected,
and Shire is working with the FDA to provide a full and timely
response to the agency's request," Shire said in a statement.




Read more at Reuters.com Government Filings News